Document is current
Any future updates will be listed below
-
Authors
Tian, Jiaxin
Feng, Jiaxin
Li, Guoping
Xue, Yanqing
Hou, Yanbin
Wu, Danjuan
Nie, Sheng
Ji, Yunxin
Ruan, Liemin
Lou, Zhongze
-
Funding
Funding for this research was provided by:
“Pioneer” and “Leading Goose” R&D Program of Zhejiang (2025C02110, 2025C02250(SD2))
Medical and Health Science and Technology Plan Project of Zhejiang Province (2023KY1062, 2023RC258)
Ningbo Key Research and Development Program (2023Z197, 2022Z145)
Ningbo Top Medical and Health Research Program (2024010317)
Ningbo Natural Science Foundation (2022J207)
- License Information
-
More Information
Article History
Received: 25 April 2025
Accepted: 4 November 2025
First Online: 8 December 2025
Declarations
:
: The project has been registered in the Chinese Clinical Trials Registry before recruiting subjects (Reg No. ChiCTR: ChiCTR2100050195, Reg time: 22/08/2021).All participants in the study were informed and signed informed consent.This study was approved by the ethical committee of Ningbo First Hospital.We carried out all procedures according to the the Helsinki declaration andits subsequent amendments. Signed informed consent were obtained onlinefrom all participants.
: Not applicable.
: The authors declare no competing interests.
